Springer US
Boston
http://www.springer-ny.com
11154
1389-9155
1573-2606
Reviews in Endocrine and Metabolic Disorders
Rev Endocr Metab Disord
Medicine & Public Health
Internal Medicine
Diabetes
Endocrinology
12
12
4
1
1
Diagnosis and Treatment of Primary Aldosteronism
10
2011
5
3
2011
5
2
2011
3
2011
Springer Science+Business Media, LLC
2011
John
Funder
9161
10.1007/s11154-011-9161-9
3
Primary aldosteronism
A Japanese perspective
11
14
2011
1
26
2011
2
9
The Author(s)
2011
Fumitoshi
Satoh
fsatoh@mail.tains.tohoku.ac.jp
Ryo
Morimoto
Yoshitsugu
Iwakura
Yoshikiyo
Ono
Masataka
Kudo
Kei
Takase
Sadayoshi
Ito
Division of Nephrology, Endocrinology, and Vascular Medicine
Tohoku University Hospital
Sendai
Miyagi
Japan
Division of Radiology
Tohoku University Hospital
Sendai
Miyagi
Japan
Abstract
Primary aldosteronism (PA) is the most common cause of secondary hypertension, accounting for 10% of all hypertension. Far from being benign, hypertension due to PA is associated with high cardiovascular morbidity and mortality. However, PA is still underdiagnosed in general practice. Recent reports strongly recommend that identifying patients with PA is cost-beneficial based on improved cardiovascular outcomes afforded by specific surgical and medical treatment. This review provides an update of PA including controversial aspects of diagnosis and treatment.
Keywords
Aldosterone producing adenoma
Adrenal venous sampling
Laparoscopic adrenalectomy
Mineralocorticoid receptor antagonists
Primary aldosreronism